Read the quarter in context.
A source-linked quarter view: reported numbers, management language, guidance, and the risks that should carry forward.
ConCallIQ research layer
Signal, with the source still visible.
Use the controls below to narrow the view, then follow the evidence into the next layer of context.
Revenue
₹18,335 Cr
verified against source
Revenue YoY
11%
reported change
EBITDA
Pending
latest reported figure
Source
nse announcements
record provenance
Actual signal trajectory
Where this quarter sits.
Quarter read
What the record says.
UPL delivered a strong FY26 with revenue up 11% to ₹52,000 crore and EBITDA up 18%, driven by volume-led growth across all regions and platforms. Contribution margin expanded 220bps to 31.5% in crop protection, while net debt/EBITDA fell to 1.6x from 2.1x. The company provided a Q1 FY27 guidance of 10-14% revenue growth and 14-18% EBITDA growth, citing cautious optimism despite Middle East supply disruptions. A key risk is the elevated ECL provision of ₹350 crore in Q4, reflecting credit stress in Latin America. Management also announced a reorganization to unlock value in Advanta and Superform, though some investors raised concerns about shareholder dilution.
Colored figures show movement against the previous available record.
Guidance to track
- Management guided Q1 FY27 revenue growth of 10-14% YoY, driven by volume and price, with FX tailwind of 7-9%.
- EBITDA growth guided at 14-18% for Q1 FY27, reflecting operating leverage despite seasonally low quarter.
- Capex expected to increase to $300-350 million from $261 million in FY26, focused on specialty chemicals and backward integration.
- Target leverage ratio of 1.2-1.5x in the medium term, with current at 1.6x; will maintain optimal capital structure.
Risks flagged
- Geopolitical tensions could increase raw material costs and working capital needs; management is managing via disciplined sourcing and pricing.
- Q4 ECL provision of ₹350 crore (full year ₹750 crore) reflects credit stress in Latin America; analyst questioned if this is the new normal.
- Analyst raised concern that the proposed demerger structure could trigger a conglomerate discount and dilute existing shareholders.
- Higher fertilizer costs may reduce farmer incomes and potentially lower agrochemical consumption, though management expects crop protection demand to hold.
Key quotes
- We are cautiously optimistic about Q1. We are already 40 days in this quarter. We have some visibility about our Q1 results.
- We don't believe in speculations and therefore we should be able to pass on whatever the cost increase has been there.
- Our strategy is very clear. We are focused on driving strong organic growth while continuing to gain market share across all of our core markets.
Research modules